Kairos Pharma, Ltd. (KAPA)

Kairos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	13	-	-	-
Enterprise Value	10	-	-	-
Debt / Equity Ratio	0.04	-0.31	-0.50	-0.34
Quick Ratio	1.92	0.04	0.27	0.04
Current Ratio	2.84	0.04	0.27	0.04
Return on Assets (ROA)	-41.71%	-107.07%	-39.41%	-
Buyback Yield / Dilution	-2.97%	-1.42%	-11.86%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q